Product Certification&
    Enterprise Certification

  • Ms.Yan
    Tel: +86-18013506594

  • Mobile:+86-18013506594
  • Tel:+86-18013506594
  • Fax:
  • URL:http://www.betterbiochem.com
  • Province/state:SHANGHAI
  • City:SHANGHAI
  • Street:No. 8 Building, 18 nong, Xi Yingnan Road, Pudong, Shanghai,China
  • MaxCard:
Home > Products >  1429881-91-3 in bulk supply 1429881-91-3 on hot selling Offer 1429881-91-3 UNC2025

1429881-91-3 in bulk supply 1429881-91-3 on hot selling Offer 1429881-91-3 UNC2025 CAS NO.1429881-91-3

  • FOB Price: USD: /Gram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: T/T,Other
  • Available Specifications:

    99%(1-5)Gram98%(1-5)Gram

  • Product Details

Keywords

  • 1429881-91-3 in bulk supply
  • 1429881-91-3 on hot selling
  • Offer 1429881-91-3 UNC2025

Quick Details

  • ProName: 1429881-91-3 in bulk supply 1429881-91...
  • CasNo: 1429881-91-3
  • Molecular Formula: C28H40N6O
  • Appearance: Powder
  • Application: Scientific research
  • DeliveryTime: Prompt
  • PackAge: As required
  • Port: Shanghai
  • ProductionCapacity: 1000 Gram/Week
  • Purity: 98%
  • Storage: keep sealed and keep from direct light
  • Transportation: By Sea/Air/FedEx
  • LimitNum: 1 Gram
  • Moisture Content: N/A
  • Impurity: N/A
  • Grade: Industrial Grade,Pharma Grade

Superiority

1429881-91-3 in bulk supply on hot selling Offer  UNC2025

UNC-2025 is a novel potent and highly orally bioavailable Mer/FLT3 dual inhibitor, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that UNC-2025 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.

UNC2025 is a potent, ATP-competitive and highly orally active Mer/Flt3 inhibitor with IC50 values of 0.74 nM and 0.8 nM, respectively. UNC2025 is >45-fold selectivity for MERTK relative to Axl (IC50= 122 nM; Ki = 13.3 nM). UNC2025 exhibits an excellent PK properties, and can be used for the investigation of acute leukemia.

 

Details

UNC2025 is a potent, orally bioavailable inhibitor of the tyrosine kinases Mer and Flt3 (IC50s = 0.74 and 0.80 nM, respectively).It less potently inhibits Axl and Tyro3 (IC50s = 14 and 17 nM, respectively) and a panel of related kinases. UNC2025 blocks colony formation of Mer- and Flt3-dependent tumor cell lines and inhibits Mer phosphorylation in bone marrow leukemia cells in vivo. Pharmacokinetic studies suggest that orally administered UNC2025 at 3 mg/kg will suffice to provide 90% inhibition of Mer and Flt3 at 30 min.

 

Identification
Name   trans-4-[2-(Butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol
Synonyms   UNC 2025
 
Molecular Structure   CAS # 1429881-91-3, trans-4-[2-(Butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol, UNC 2025
 
Molecular Formula   C28H40N6O
Molecular Weight   476.66
CAS Registry Number   1429881-91-3
 
Properties
 
Solubility   Insuluble (1.3E-3 g/L) (25 ºC), Calc.*
Density   1.24±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
     
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog